NYSEInformation TechnologyScientific & Technical InstrumentsSnapshot 2026-07-07
Reading COHR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track COHR free→QuarterlyIQ Insights · COHR
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. Current price $314.08. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $314 COHR trades at 68× p/e, in line with its 56× p/e peer median — but our blended $195 fair value sits well below the price. We hold it with medium confidence: our number sits below the analyst range. Analysts target $230–$455. Note: our $195 fair value sits below the entire analyst range ($230–$455). Not investment advice.
$230.00 – $455.00 (median $371.00) · 7 analysts · as of 2026-07-02
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Flags: expensive valuation, weak execution quality. Capped at elevated by the Mania regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $371.00 | — | — | Analyst | high |
| graham number | 12M | $76.45 | — | — | TTM | high |
| Mgmt guidance | 12M | $193.80 | 56.2 | 3.45 | Mgmt | high |
| Peer EV/EBITDA | 12M | $53.95 | 18.1 | 3.45 | TTM | high |
| Peer P/E | 12M | $202.08 | 56.2 | 3.60 | TTM | high |
| Peer P/S | 12M | $165.75 | 4.9 | 33.62 | TTM | high |
| PEG | 12M | $88.28 | 24.5 | 3.60 | TTM | high |
| residual income | 12M | $49.65 | — | — | TTM | high |
| Own P/E history | 12M | $167.05 | 46.4 | 3.60 | TTM | high |
| triangulated | 12M | $270.30 | 56.2 | 4.81 | Triangulated | high |
| Mgmt guidance | 3Y | $1109.07 | 56.2 | 19.74 | Mgmt(prov.) | medium |
| Peer P/E | 3Y | $100.68 | 56.2 | 1.79 | Analyst | medium |
| Peer P/S | 3Y | $168.67 | 4.9 | 34.21 | guidance | medium |
| PEG | 3Y | $43.98 | 24.5 | 1.79 | Analyst | medium |
| Own P/E history | 3Y | $83.23 | 46.4 | 1.79 | Analyst | medium |
| Peer P/E | 5Y | $50.16 | 56.2 | 0.89 | Analyst | high |
| Peer P/S | 5Y | $84.03 | 4.9 | 17.05 | guidance | high |
| Own P/E history | 5Y | $41.46 | 46.4 | 0.89 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
